Asia Pacific Capnography Equipment Market

The Asia Pacific capnography equipment market is projected to reach USD 0.13 billion by 2031 from USD 0.10 billion in 2026, at a CAGR of 5.9% during the forecast period.

The Asia Pacific capnography equipment market is witnessing growth as healthcare infrastructure is rapidly expanding. With the rising number of surgical procedures and increasing ICU and emergency care admissions in countries like China, India, and Japan, the demand is also increasing. The market is further being stimulated by the increasing incidence of chronic respiratory diseases, a growing elderly population, and greater awareness among clinicians of patient safety and the importance of early detection of respiratory complications, thereby increasing demand for capnography during anesthesia and mechanical ventilation. Moreover, the government’s trend toward hospital modernization, along with the growing adoption of advanced, portable, and integrated patient monitoring systems, is providing significant support to the market. Additionally, ongoing technological advancements and the declining cost of capnography devices are driving their adoption by hospitals, ambulatory surgical centers, and emergency medical services in the Asia Pacific region.

Some of the prominent players operating in the market include Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Masimo (US), GE Healthcare (US), and Becton, Dickinson and Company (US), among others.

To know about the assumptions considered for the study download the pdf brochure

Medtronic, Koninklijke Philips N.V., Masimo, GE Healthcare, and Becton, Dickinson and Company are leading players in the Asia Pacific capnography equipment market. They owe the regional dominance to a combination of factors like well-established local distribution networks, strong brand awareness, and closely knit relationships with hospitals and healthcare systems. The companies provide highly advanced, clinically proven capnography products that are typically incorporated into multi-parameter patient monitors used in operating rooms, ICUs, and emergency departments. Besides, their constant dedication to R&D, collaboration with local healthcare providers, and the capacity to provide medical training, service support, and healthcare solutions tailored to various healthcare settings significantly increase adoption in both emerging and mature Asia Pacific markets. Moreover, their competitive pricing strategies and adherence to regional regulatory standards enable them to expand their reach into both public and private healthcare facilities.

In September 2025, Masimo and Philips renewed and expanded their strategic partnership to accelerate the integration and market adoption of Masimo’s advanced monitoring technologies into Philips’ patient monitoring platforms. This collaboration also includes co-development and promotion of next-generation AI-driven monitoring solutions, which can further enhance respiratory monitoring capabilities. For the Asia Pacific capnography equipment market, this expanded alliance may drive broader deployment of integrated capnography features in multi-parameter monitors.

In June 2025, Philips has deepened its long-term collaboration with Medtronic through a new multi-year agreement aimed at broadening access to advanced patient monitoring technologies, including integrated systems that bundle consumables and validated monitoring solutions such as Microstream capnography. While the initial focus is on global expansion beyond North America, the move signals increased availability and streamlined procurement of integrated monitoring solutions (including capnography) that can support clinicians in emerging healthcare markets such as the Asia Pacific, where demand for multi-parameter and respiratory monitoring technologies is growing as health systems expand critical care capacity.

Medtronic (Ireland)

Medtronic is a large and diverse medical technology company, with one of its legal headquarters located in Dublin, Ireland. The firm operates in over 150 countries and employs more than 90,000 people. The company offers a wide range of health products, including high-tech patient monitoring devices, e.g., its Microstream capnography systems, which continuously monitor end-tidal CO2 across different clinical environments, from anesthesiology to intensive care. These systems integrate with multiple-parameter monitoring platforms and aim to enhance the accuracy of respiratory monitoring and the early detection of respiratory compromise, which is crucial for perioperative and ICU care. In the Asia Pacific region, Medtronic’s strong market position is enabled by its global scale, strategic partnerships (for example, the integration of Microstream capnography with leading monitoring systems), and dedicated initiatives to expand the availability of life-saving technologies in both developed and emerging markets. Besides its participation in regional innovation projects and cooperation with local healthcare systems, the company further benefits from these factors in the implementation of its respiratory monitoring solutions. This aligns with the growing need for capnography devices, driven by the rising number of surgeries, the demand for critical care facilities, and investments in modern healthcare infrastructure in countries such as China, India, and Southeast Asia.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V., commonly known as Philips, is a health technology company headquartered in Amsterdam, Netherlands. It is a leading player globally in patient monitoring and connected care solutions, with a strong presence. Philips offers a wide range of products, including respiratory and capnography monitoring systems. The available products include standalone CO sensors and capnography modules integrated into Philips patient monitoring platforms. The clinical environments that benefit most from such solutions include operating rooms, intensive care units, emergency departments, and general wards. The company has vast knowledge and experience in multiparameter monitoring and connected care that allow for the simple and easy incorporation of capnography data in clinical workflows, thus enhancing respiratory assessment and patient safety. Philips leverages its well-known brand name, extensive distribution network, and strategic partnerships in the Asia Pacific region to localize products and tailor market strategies. This approach drives the adoption of high-end capnography solutions as healthcare infrastructure and critical care services evolve in markets such as China, India, Japan, and Southeast Asia. The hallmark features of Philips products include innovation, interoperability, and ease of use for physicians and clinicians. These characteristics align well with the increasing demand for real-time respiratory monitoring in anesthesia, emergency, and critical care departments. Consequently, this strengthens Philips’ position in the growing regional market for capnography equipment.

Market Ranking

The Asia Pacific capnography equipment industry is somewhat consolidated, predominantly led by multinational patient monitoring companies that have strong hospital outreach and extensive service networks. Due to their large installed base of multi-parameter patient monitors with integrated capnography modules, wide distribution reach, and long-standing relationships with tertiary hospitals, Koninklijke Philips N.V. and GE Healthcare are the market leaders. Medtronic, with its microstream capnography technology, is a significant competitor in the market. The company is also leveraging strategic partnerships to gain deeper access to anesthesia and critical care workflows, thereby gaining a foothold in both developed and emerging healthcare systems in the Asia Pacific region. Masimo is enhancing its position through its internally developed NomoLine capnography and advanced sensor technologies, which are increasingly used in perioperative and emergency care settings to provide high-precision respiratory monitoring. Becton, Dickinson and Company maintains a strong market position by focusing on disposables, airway management, and integrated monitoring accessories. This focus provides it with an advantage in hospital procurement networks. Together with other leading firms, it holds a significant market share due to its technological leadership, extensive product portfolio, and ability to manage large-scale hospital deployments in the Asia Pacific region.

Related Reports:

Asia Pacific Capnography Equipment Market by Product (Multiparameter, Standalone, Software, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Respiratory Monitoring), End User (Hospitals, ASC) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com